PAH Risk Assessment: Overview and Review of PVD NetWork Survey
Vijay Balasubramanian, MD, FCCP, Medical Director of Pulmonary Hypertension-Community Regional Medical Center at UCSF Fresno, and Jean Elwing, MD, FCCP, Director of the Pulmonary Hypertension Program at the University of Cincinnati Health in Ohio, discuss the results of the Pulmonary Vascular Disease NetWork’s survey on how clinicians have implemented risk assessment tools to evaluate and monitor patients with pulmonary arterial hypertension.